M. Knowling
British Columbia Cancer Agency
600 West 10th Avenue
Vancouver
BC, V5Z 4E6
Name/email consistency: high
- A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial. Knowling, M., Blackstein, M., Tozer, R., Bramwell, V., Dancey, J., Dore, N., Matthews, S., Eisenhauer, E. Invest. New. Drugs (2006)
- A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer. Knowling, M., Browman, G., Siu, L., Khoo, K., Cooke, A., Tannock, I., Klaassen, D., Cripps, C., Goss, G., Matthews, S., Clarke, R., Seymour, L. Ann. Oncol. (2001)